Gadolinium MRI contrast agents linked to Nephrogenic Systemic Fibrosis
Gadolinium based MRI contrast agents and Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NFD) have been linked in yet another study. This time, researchers in Scotland have confirmed that gadolinium based contrast agents used in MRI’s are strongly associated with the onset of this often fatal disorder in people suffering from pre-existing kidney disease. Their findings only add to the growing body of evidence that shows a strong connection between NSF/NFD and gadolinium based contrast agents that are often used in MRIs.
![[ Beasley Allen Law Firm Logo ]](http://www.gadolinium-lawsuit.com/wp-content/themes/system-unity/images/logo.png)